EntryPoint Capital’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$426K Buy
45,225
+10,901
+32% +$103K 0.21% 148
2025
Q1
$186K Buy
+34,324
New +$186K 0.09% 554
2024
Q4
Sell
-38,700
Closed -$309K 806
2024
Q3
$309K Buy
+38,700
New +$309K 0.18% 238
2024
Q1
Sell
-5,608
Closed -$130K 1527
2023
Q4
$130K Buy
+5,608
New +$130K 0.12% 251